MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1 | |
Liu, Y.; Niu, Z.; Lin, X.; Tian, Y. | |
刊名 | CANCER GENE THERAPY |
2017 | |
卷号 | 24期号:5页码:208-214 |
DOI | 10.1038/cgt.2017.6 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4588758 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Prov Hosp, Dept Obstet & Gynecol, 324 Jingwu Rd, Jinan 250021, Peoples R China. 2.[Liu, Y. 3.Niu, |
推荐引用方式 GB/T 7714 | Liu, Y.,Niu, Z.,Lin, X.,et al. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1[J]. CANCER GENE THERAPY,2017,24(5):208-214. |
APA | Liu, Y.,Niu, Z.,Lin, X.,&Tian, Y..(2017).MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.CANCER GENE THERAPY,24(5),208-214. |
MLA | Liu, Y.,et al."MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1".CANCER GENE THERAPY 24.5(2017):208-214. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论